4,4,5,5-TETRAMETHYL-2-(4-((4-(TRIFLUOROMETHYL)BENZYL)OXY)PHENYL)-1,3,2-DIOXABOROLANE, 95%, 250mg

2-Bromo-5-hydroxybenzaldehyde>97.0%(GC)1g

tert-Butyl 4-Bromo-1H-pyrazole-1-carboxylate, 97.0%, 100g

5-Methyl-2-(3-trifluoromethyl-phenylamino)-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

1-Benzyl-3,3-dimethylpiperidin-4-one, 95.0%, 10g

p-Anisic Acid>99.0%(GC)(T)500g

Methyl 5-nitro-1H-pyrazole-3-carboxylate, 95.0%, 25g

4-Fluorophenyl Acetate>98.0%(GC)5g

4-[(3-FLUOROPHENYL)(METHYL)AMINO]BENZALDEHYDE, 95.0%, 1g

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 98%, 10g

3-(4-(Benzyloxy)benzylidene)piperidine hydrochloride, 250mg

4-Chloroquinazolin-6-yl acetate, 98%, 100mg

n-Nonano, 99%, per sintesi, 250 ml, confezione in vetro